Imipramine kinetics in the single pass rat liver perfusion model

Area of Science:

• Pharmacokinetics
• Drug Metabolism
• Liver Physiology

Background:

• Imipramine is a tricyclic antidepressant.
• Understanding imipramine's metabolic pathways is crucial for clinical application.
• Rat liver perfusion models offer insights into drug elimination.

Purpose of the Study:

• To investigate imipramine elimination and metabolism in a rat liver perfusion model.
• To characterize the pathways of imipramine and desipramine elimination.
• To explore factors affecting steady-state imipramine concentrations.

Main Methods:

• Single-pass rat liver perfusion with constant flow and pressure.
• Continuous and single-dose imipramine administration.
• Analysis of imipramine and desipramine in outflow medium and bile.

Main Results:

• Imipramine eliminated as unchanged drug, desipramine, and glucuronide conjugates.
• Desipramine further metabolized to unchanged drug or glucuronide conjugates.
• Difficulties in achieving steady state during constant infusion, likely due to declining elimination rates.
• Dose-dependent elimination suggesting saturation kinetics.

Conclusions:

• Imipramine undergoes complex metabolism and elimination in the liver.
• Saturation kinetics and potential changes in elimination rates impact imipramine pharmacokinetics.
• Rat liver perfusion is a valuable tool for studying drug metabolism and elimination.